CDTNet PhD Fellow
GE HealthCare
This listing was originally posted on GE HealthCare's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moHeart valve disease affects millions of people worldwide and relies heavily on medical imaging for diagnosis, treatment planning and patient follow-up. Echocardiography is the most widely used imaging technique for assessing valve function, but the development of reliable artificial intelligence tools for image analysis is often limited by the availability of large, high-quality, annotated datasets. Creating and annotating such datasets is expensive and time-consuming, creating a significant barrier to innovation.
This project will investigate how generative artificial intelligence can be used to improve the assessment of mitral valve diseases in particular mitral regurgitation. The doctoral candidate will develop novel methods analysing different echocardiography data modalities such as b-mode or colorflow and investigate how generating synthetic echocardiographic images can support automated image analysis tasks, such as valve segmentation and the assessment of mitral valve regurgitation. Attention will be given to understanding how patient-specific information can be incorporated into generative models to improve accuracy, consistency and clinical relevance.
Working at the interface of artificial intelligence, medical imaging and cardiovascular medicine, the candidate will evaluate how generated synthetic data can improve the performance and robustness of machine-learning models when compared with training approaches utilising real world data alone. The project will make use of both proprietary clinical datasets and publicly available resources. Ultimately, the developed methods will be integrated into clinical software and evaluated as part of a prospective study of automated mitral valve assessment.
The project provides a unique opportunity to contribute to the next generation of AI-enabled cardiac imaging technologies within a leading industrial research environment, while benefiting from close collaboration with academic and clinical partners across Europe.
● Oslo University Hospital, Norway (3 months): retrospective analysis of mitral valve regurgitation and validation of automated assessment methods.
● IDIBAPS, Barcelona, Spain (2 months): design and implementation of a prospective clinical study for automated mitral valve assessment.
● King's College London, United Kingdom (2 months): investigation of how mechanistic cardiovascular models can complement machine-learning approaches.
We are looking for a highly motivated and solution-oriented applicant with a strong machine learning background. The ideal candidate will have:
GE HealthCare is an Equal Opportunity Employer where inclusion matters. Employment decisions are made without regard to race, color, religion, national or ethnic origin, sex, sexual orientation, gender identity or expression, age, disability, protected veteran status or other characteristics protected by law.
We expect all employees to live and breathe our behaviors: to act with humility and build trust; lead with transparency; deliver with focus, and drive ownership – always with unyielding integrity.
Our total rewards are designed to unlock your ambition by giving you the boost and flexibility you need to turn your ideas into world-changing realities. Our salary and benefits are everything you’d expect from an organization with global strength and scale, and you’ll be surrounded by career opportunities in a culture that fosters care, collaboration and support.
#LI-MG1
Relocation Assistance Provided: No
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at GE HealthCare?
Help others prepare — share your experience anonymously.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo